Literature DB >> 7580385

Do pharmaceutical representatives misuse their drug samples?

K L Tong1, C Y Lien.   

Abstract

OBJECTIVE: To determine the extent to which pharmaceutical representatives misuse their samples.
DESIGN: Voluntary questionnaire survey.
SETTING: A family practice office. PARTICIPANTS: Pharmaceutical representatives visiting the office during a 3-month period. MAIN OUTCOME MEASURES: Number of surveyed representatives who self-medicated, provided samples of prescription drugs to nonphysicians, or exchanged drugs with other representatives; classes of prescription drugs most commonly used; and beneficiaries.
RESULTS: Of the 27 representatives surveyed, 16 (59.2%) have provided prescription drug samples to individuals other than physicians. Thirteen (48.1%) either self-medicated or provided samples to friends or relatives. Seven (25.9%) have exchanged drug samples with other representatives. Eleven (40.7%) of the 27 surveyed had not sampled prescription drugs themselves, given them to others, or exchanged drugs with other representatives. The most commonly sampled drugs were nonsteroidal anti-inflammatory drugs. Drug samples were most often given to friends and spouses.
CONCLUSION: Self-medication and giving samples to nonphysicians were practised by almost 60% of surveyed representatives. Representatives usually caution recipients, however, and there are very few complications. Drugs with potential for abuse or dependence and cardiovascular medications were rarely used.

Entities:  

Mesh:

Year:  1995        PMID: 7580385      PMCID: PMC2146346     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  3 in total

1.  A community survey of self-medication activities.

Authors:  A Segall
Journal:  Med Care       Date:  1990-04       Impact factor: 2.983

2.  Pharmacists recovering from alcohol and other drug addictions: an interview study.

Authors:  L Bissell; P W Haberman; R L Williams
Journal:  Am Pharm       Date:  1989-06

3.  Prevalence of substance use among US physicians.

Authors:  P H Hughes; N Brandenburg; D C Baldwin; C L Storr; K M Williams; J C Anthony; D V Sheehan
Journal:  JAMA       Date:  1992-05-06       Impact factor: 56.272

  3 in total
  4 in total

1.  Free drug samples in the United States: characteristics of pediatric recipients and safety concerns.

Authors:  Sarah L Cutrona; Steffie Woolhandler; Karen E Lasser; David H Bor; David U Himmelstein; William H Shrank; Neal S LeLeiko
Journal:  Pediatrics       Date:  2008-10       Impact factor: 7.124

2.  Characteristics of recipients of free prescription drug samples: a nationally representative analysis.

Authors:  Sarah L Cutrona; Steffie Woolhandler; Karen E Lasser; David H Bor; Danny McCormick; David U Himmelstein
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

Review 3.  Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review.

Authors:  Lina Alkhaled; Lara Kahale; Hala Nass; Hneine Brax; Racha Fadlallah; Kamal Badr; Elie A Akl
Journal:  BMJ Open       Date:  2014-07-01       Impact factor: 2.692

4.  No more free drug samples?

Authors:  Susan Chimonas; Jerome P Kassirer
Journal:  PLoS Med       Date:  2009-05-12       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.